GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.732
+0.0229 (+3.23%)
At Close: Apr 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.631 $0.96 Wednesday, 17th Apr 2024 CARA stock ended at $0.732. This is 3.23% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 6.86% from a day low at $0.700 to a day high of $0.748.
90 days $0.500 $1.15
52 weeks $0.500 $4.67

Historical Cara Therapeutics prices

Date Open High Low Close Volume
2021-09-15 $14.57 $15.04 $14.55 $14.77 598 540
2021-09-14 $15.00 $15.00 $14.49 $14.63 569 784
2021-09-13 $15.27 $15.29 $14.64 $14.90 710 684
2021-09-10 $15.60 $15.80 $15.23 $15.27 576 864
2021-09-09 $15.52 $15.83 $15.32 $15.56 670 627
2021-09-08 $15.55 $15.76 $15.25 $15.54 793 528
2021-09-07 $15.25 $15.85 $15.16 $15.62 798 476
2021-09-03 $15.64 $15.74 $15.10 $15.24 1 015 688
2021-09-02 $16.00 $16.28 $15.59 $15.74 1 233 466
2021-09-01 $15.89 $16.08 $15.57 $16.06 1 233 218
2021-08-31 $14.73 $15.83 $14.66 $15.78 1 735 281
2021-08-30 $14.17 $15.07 $14.15 $14.83 1 822 971
2021-08-27 $13.62 $14.89 $13.60 $14.58 2 875 840
2021-08-26 $14.16 $14.33 $13.40 $13.66 2 317 102
2021-08-25 $14.34 $14.63 $13.64 $14.27 5 443 868
2021-08-24 $17.29 $18.25 $14.53 $14.88 37 301 539
2021-08-23 $14.11 $14.64 $13.55 $14.28 4 476 311
2021-08-20 $12.45 $13.90 $12.33 $13.70 1 870 596
2021-08-19 $12.90 $13.29 $12.36 $12.41 840 864
2021-08-18 $13.09 $13.36 $12.77 $13.07 731 959
2021-08-17 $12.60 $12.98 $12.33 $12.72 682 292
2021-08-16 $14.12 $14.12 $12.50 $12.54 1 252 133
2021-08-13 $13.52 $14.02 $13.18 $13.85 1 208 387
2021-08-12 $13.10 $13.39 $12.78 $13.33 596 799
2021-08-11 $13.44 $13.47 $12.91 $13.12 799 621
Click to get the best stock tips daily for free!

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Golden Star

Ticker Date Change Price
ITCI Apr 05 12.05% $68.44
AKR Apr 05 0.665% $16.53
SARK Mar 28 16.07% $26.88
ARCC Mar 25 1.04% $20.12
STT Mar 19 0.262% $72.62
GGB Mar 19 0.468% $4.27
CAG Mar 18 7.16% $28.22
JBI Mar 15 1.29% $14.72
MASI Mar 14 3.34% $132.20
CMC Mar 14 5.04% $53.19
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT